{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:14:31Z","timestamp":1788606871226,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shangyu Science and Technology Bureau Project","award":["2021-02"],"award-info":[{"award-number":["2021-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17147-2","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T13:47:01Z","timestamp":1756216021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["PKM2 regulates angiogenic activation via ANGPT2 in endothelial cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Qiangqiang","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"17147_CR1","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.305368","volume":"116","author":"PJ Psaltis","year":"2015","unstructured":"Psaltis, P. J. & Simari, R. D. Vascular wall progenitor cells in health and disease. Circ. Res. 116, 1392\u20131412 (2015).","journal-title":"Circ. Res."},{"key":"17147_CR2","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/cvr\/cvad076","volume":"119","author":"X Wang","year":"2023","unstructured":"Wang, X., Shen, Y., Shang, M., Liu, X. & Munn, L. L. Endothelial mechanobiology in atherosclerosis. Cardiovasc. Res. 119, 1656\u20131675 (2023).","journal-title":"Cardiovasc. Res."},{"key":"17147_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41569-018-0030-z","volume":"15","author":"Z Ungvari","year":"2018","unstructured":"Ungvari, Z. et al. Endothelial dysfunction and angiogenesis impairment in the ageing vasculature. Nat. Rev. Cardiol. 15, 555\u2013565 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"17147_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249\u2013257 (2000).","journal-title":"Nature"},{"key":"17147_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","volume":"26","author":"AC Dudley","year":"2023","unstructured":"Dudley, A. C. & Griffioen, A. W. Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis 26, 313\u2013347 (2023).","journal-title":"Angiogenesis"},{"key":"17147_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/CIRCRESAHA.120.316851","volume":"127","author":"G Eelen","year":"2020","unstructured":"Eelen, G., Treps, L., Li, X. & Carmeliet, P. Basic and therapeutic aspects of angiogenesis updated. Circ. Res. 127, 310\u2013329 (2020).","journal-title":"Circ. Res."},{"key":"17147_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2015.08.004","author":"WJ Israelsen","year":"2015","unstructured":"Israelsen, W. J. & Vander Heiden, M. G. Pyruvate kinase: function, regulation and role in cancer. Seminars Cell. Dev. Biology. https:\/\/doi.org\/10.1016\/j.semcdb.2015.08.004 (2015).","journal-title":"Seminars Cell. Dev. Biology"},{"key":"17147_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","volume":"21","author":"EM Palsson-McDermott","year":"2015","unstructured":"Palsson-McDermott, E. M. et al. Pyruvate kinase M2 regulates Hif-1\u03b1 activity and IL-1\u03b2 induction and is a critical determinant of the Warburg effect in LPS-Activated macrophages. Cell. Metab. 21, 65\u201380 (2015).","journal-title":"Cell. Metab."},{"key":"17147_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nature11540","volume":"491","author":"B Chaneton","year":"2012","unstructured":"Chaneton, B. et al. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491, 458\u2013462 (2012).","journal-title":"Nature"},{"key":"17147_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.canlet.2020.11.018","volume":"503","author":"S Zhu","year":"2021","unstructured":"Zhu, S. et al. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics. Cancer Lett. 503, 240\u2013248 (2021).","journal-title":"Cancer Lett."},{"key":"17147_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nchembio.1060","volume":"8","author":"D Anastasiou","year":"2012","unstructured":"Anastasiou, D. et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat. Chem. Biol. 8, 839\u2013847 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"17147_CR12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ncb2629","volume":"14","author":"W Yang","year":"2012","unstructured":"Yang, W. et al. ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat. Cell. Biol. 14, 1295\u20131304 (2012).","journal-title":"Nat. Cell. Biol."},{"key":"17147_CR13","doi-asserted-by":"publisher","first-page":"102458","DOI":"10.1016\/j.redox.2022.102458","volume":"56","author":"Q Zhou","year":"2022","unstructured":"Zhou, Q. et al. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biol. 56, 102458 (2022).","journal-title":"Redox Biol."},{"key":"17147_CR14","doi-asserted-by":"publisher","first-page":"6204","DOI":"10.1002\/jcp.29549","volume":"235","author":"R Ren","year":"2020","unstructured":"Ren, R. et al. PKM2 regulates angiogenesis of VR-EPCs through modulating glycolysis, mitochondrial fission, and fusion. J. Cell. Physiol. 235, 6204\u20136217 (2020).","journal-title":"J. Cell. Physiol."},{"key":"17147_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1158\/0008-5472.CAN-21-0403","volume":"82","author":"Y Xia","year":"2022","unstructured":"Xia, Y. et al. PKM2 is essential for bladder cancer growth and maintenance. Cancer Res. 82, 571\u2013585 (2022).","journal-title":"Cancer Res."},{"key":"17147_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/ATVBAHA.121.317102","volume":"42","author":"N Khosraviani","year":"2022","unstructured":"Khosraviani, N., Wu, R. & Fish, J. E. Angiopoietin-2: an emerging tie to pathological vessel enlargement. Arterioscler. Thromb. Vasc Biol. 42, 3\u20135 (2022).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"17147_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.placenta.2017.03.021","volume":"56","author":"Q Wang","year":"2017","unstructured":"Wang, Q. & Lash, G. E. Angiopoietin 2 in placentation and tumor biology: the Yin and Yang of vascular biology. Placenta 56, 73\u201378 (2017).","journal-title":"Placenta"},{"key":"17147_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.canlet.2014.09.035","volume":"380","author":"NM Biel","year":"2016","unstructured":"Biel, N. M. & Siemann, D. W. Targeting the Angiopoietin-2\/Tie-2 axis in conjunction with VEGF signal interference. Cancer Lett. 380, 525\u2013533 (2016).","journal-title":"Cancer Lett."},{"key":"17147_CR19","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1158\/0008-5472.CAN-22-2838","volume":"83","author":"HR Park","year":"2023","unstructured":"Park, H. R. et al. Angiopoietin-2-Dependent Spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma. Cancer Res. 83, 1968\u20131983 (2023).","journal-title":"Cancer Res."},{"key":"17147_CR20","doi-asserted-by":"crossref","unstructured":"Zhao, Y. et al. Activated mesangial cells induce glomerular endothelial cells proliferation in rat anti-Thy\u20101 nephritis through VEGFA\/VEGFR2 and Angpt2\/Tie2 pathway. Cell Prolif 54, (2021).","DOI":"10.1111\/cpr.13055"},{"key":"17147_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10456-015-9475-4","volume":"18","author":"T Ma","year":"2015","unstructured":"Ma, T. et al. KSHV induces aerobic Glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in kaposi\u2019s sarcoma. Angiogenesis 18, 477\u2013488 (2015).","journal-title":"Angiogenesis"},{"key":"17147_CR22","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Organophosphorus flame retardants and metabolic disruption: an in silico, in vitro, and in vivo study focusing on adiponectin receptors. Environ Health Perspect 132, (2024).","DOI":"10.1289\/EHP14634"},{"key":"17147_CR23","doi-asserted-by":"publisher","first-page":"11568","DOI":"10.1038\/s41598-020-67289-8","volume":"10","author":"G Carpentier","year":"2020","unstructured":"Carpentier, G. et al. Angiogenesis analyzer for ImageJ - A comparative morphometric analysis of \u2018endothelial tube formation assay\u2019 and \u2018fibrin bead assay\u2019. Sci. Rep. 10, 11568 (2020).","journal-title":"Sci. Rep."},{"key":"17147_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tem.2012.06.010","volume":"23","author":"W Luo","year":"2012","unstructured":"Luo, W. & Semenza, G. L. Emerging roles of PKM2 in cell metabolism and cancer progression. Trends Endocrinol. Metab. 23, 560\u2013566 (2012).","journal-title":"Trends Endocrinol. Metab."},{"key":"17147_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-015-0490-2","volume":"15","author":"N Azoitei","year":"2016","unstructured":"Azoitei, N. et al. PKM2 promotes tumor angiogenesis by regulating HIF-1\u03b1 through NF-\u03baB activation. Mol. Cancer. 15, 3 (2016).","journal-title":"Mol. Cancer"},{"key":"17147_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41569-022-00770-1","volume":"20","author":"E Trimm","year":"2023","unstructured":"Trimm, E. & Red-Horse, K. Vascular endothelial cell development and diversity. Nat. Rev. Cardiol. 20, 197\u2013210 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"17147_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41401-021-00647-y","volume":"43","author":"WS Leung, Susan","year":"2022","unstructured":"Leung, Susan, W. S. & Shi, Y. The glycolytic process in endothelial cells and its implications. Acta Pharmacol. Sin. 43, 251\u2013259 (2022).","journal-title":"Acta Pharmacol. Sin"},{"key":"17147_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000088478","volume":"69","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet, P. VEGF as a key mediator of angiogenesis in cancer. Oncology 69, 4\u201310 (2005).","journal-title":"Oncology"},{"key":"17147_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard, C. & Larriv\u00e9e, B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis 20, 409\u2013426 (2017).","journal-title":"Angiogenesis"},{"key":"17147_CR30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","volume":"388","author":"GC Jayson","year":"2016","unstructured":"Jayson, G. C., Kerbel, R., Ellis, L. M. & Harris, A. L. Antiangiogenic therapy in oncology: current status and future directions. Lancet 388, 518\u2013529 (2016).","journal-title":"Lancet"},{"key":"17147_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ctrv.2018.10.008","volume":"71","author":"M Pozzari","year":"2018","unstructured":"Pozzari, M. et al. Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): when cytoreduction is the aim. A critical review with meta-analysis. Cancer Treat. Rev. 71, 39\u201346 (2018).","journal-title":"Cancer Treat. Rev."},{"key":"17147_CR32","first-page":"539","volume":"24","author":"T Ochiumi","year":"2004","unstructured":"Ochiumi, T. et al. Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma. Int. J. Oncol. 24, 539\u2013547 (2004).","journal-title":"Int. J. Oncol."},{"key":"17147_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12964-020-00535-8","volume":"18","author":"J Xie","year":"2020","unstructured":"Xie, J. et al. Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma. Cell. Commun. Signal. 18, 46 (2020).","journal-title":"Cell. Commun. Signal."},{"key":"17147_CR34","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1172\/JCI120912","volume":"128","author":"B Kim","year":"2018","unstructured":"Kim, B. et al. Endothelial pyruvate kinase M2 maintains vascular integrity. J. Clin. Invest. 128, 4543\u20134556 (2018).","journal-title":"J. Clin. Invest."},{"key":"17147_CR35","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.119.043067","volume":"141","author":"A Magadum","year":"2020","unstructured":"Magadum, A. et al. Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration. Circulation 141, 1249\u20131265 (2020).","journal-title":"Circulation"},{"key":"17147_CR36","first-page":"22","volume":"9","author":"P Luo","year":"2022","unstructured":"Luo, P. et al. Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect. Mil Med. Res. 9, 22 (2022).","journal-title":"Mil Med. Res."},{"key":"17147_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/ctrv.2000.0175","volume":"26","author":"MT Meinardi","year":"2000","unstructured":"Meinardi, M. T. et al. Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat. Rev. 26, 429\u2013447 (2000).","journal-title":"Cancer Treat. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17147-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17147-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17147-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:38:59Z","timestamp":1757435939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17147-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17147"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17147-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31448"}}